Posters
CKM: Clinical - Screening, Population Management, Care Disparities, and Patient-Centered Outcomes
October 24, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Cerebral Microvascular Integrity in Patients with CKD: A Comparative Study of Peak Width of Skeletonized Mean Diffusivity According to Dialysis Status
Prevalence of Uncontrolled and Resistant Hypertension in a Latin Population in Primary Care Facilities: A Prospective Observational Study
Cardiovascular Testing Among Veterans with CKD
Frequency of Urine Albumin Monitoring Among US Veterans with Albuminuria
Who Gets Missed During Kidney Disease Screening in Type 2 Diabetes? A Detection-Gap Analysis of Creatinine, eGFR, and Albuminuria
Under the Radar: Gaps in Urine Albumin-to-Creatinine Ratio Testing and High-Risk Albuminuria in Type 1 Diabetes
Proteinuria Screening and Renoprotective Interventions in Hypertensive Patients with and Without Diabetes
Improving CKD Screening for Patients with Diabetes in Primary Care Using Point-of-Care Urine Albumin-to-Creatinine Ratio Testing
Early Effect of a Statewide Nephrology-Primary Care Collaborative to Improve Albuminuria Screening in Patients with Type 2 Diabetes
Simple Interventions, Measurable Impact: Improving Nephropathy Screening Rates in Patients with Diabetes in Primary Care Clinic, a Quality Improvement Project
Early Detection of Diabetic Nephropathy via Single-Photon Emission CT (SPECT)/CT Imaging of Intravenously Administered Technetium Tc 99m Tilmanocept
Diabetic Kidney Disease Screening at a Tertiary Academic Center
Delays in Nephrology Care Among Patients with Diabetes at High Risk for ESKD
Prescribing Patterns for Renoprotective Medications in Diabetic Kidney Disease
Implementing a Population-Based Testing and Follow-Up Program for Primary Aldosteronism (PA) in Resistant Hypertension (RH): A Pilot Electronic Health Record (EHR)-Driven Approach
Cardiovascular-Kidney-Metabolic Syndrome Integration for Addressing CKD in Primary Care
A Structured Provider Education Program Increased Guideline-Directed Medical Therapy (GDMT) for CKD and Reduced Hyperkalemia in a Network of Nephrology Practices
National Survey of Blood Pressure Management in Peritoneal Dialysis
Barriers to Use of Evidence-Based Medication Therapy in Cardiovascular-Kidney-Metabolic Syndrome: A Qualitative Study
Guideline-Directed Medical Therapy Use in Patients with Diabetes and CKD in a Diverse Urban Cohort
Effect of a Collaborative Management Program on Albuminuria Monitoring and Use of Guideline-Directed Medical Therapy (GDMT) in High-Risk Patients with Diabetes
Contemporary Use of Guideline-Directed Medical Therapy in US Adults with Advanced CKD and High Risk of Cardiovascular Events
Use of Guideline-Directed Medical Therapy in Patients with Diabetes, CKD, and Heart Failure: A Single-Center Study Based on CKD Stage and Heart Failure Phenotype
Utilization Rates of SGLT2 Inhibitors, RAS Inhibition, GLP-1 Receptor Agonists, and Finerenone in Patients with CKD (eGFR = 30-89 mL/min/1.73 m2) and Type 2 Diabetes
Integrating Pharmacists into Cardiovascular-Kidney-Metabolic Care Teams: Results from a Learning and Action Collaborative
Pharmacist-Clinician Collaboration to Optimize SGLT2 Inhibitor Prescribing in a Rural Veterans Affairs (VA) Primary Care Clinic: A Quality Improvement Initiative
Clinician and Clinical Pharmacist Perspectives on Pharmacist-Guided Self-Management of Hypertension in Patients with CKD
Clinical Pharmacist Involvement and Kidney-Protective Medication Use in CKD
Following Primary Aldosteronism Screening: Challenges of Controlling Persistent Hypertension in Real-World Clinical Practice
Renin-Independent Aldosterone Production and Kidney Outcomes Beyond Primary Aldosteronism: Real-World Evidence from a Large Health Care Database
From Silos to Integration: Infrastructure and Initial Experience of a Cardiovascular-Kidney-Metabolic (CKM) Clinic
Changes in Gout Management and Outcomes After Referral from Primary Care to Nephrology: A Retrospective Claims Analysis
Potential Effects of Close Follow-Up After Hospitalization on Use of Guideline-Directed Medical Therapy in Patients with Cardiorenal Metabolic Syndrome
A Multidisciplinary Quality Improvement (QI) Project to Optimize Medication Management for Diabetic Nephropathy in Primary Care
Glucose Time in Range and Cause-Specific Hospitalization in Dialysis
Reduced Cardiovascular Functional Capacity (Peak VO2) Is Associated with Higher Coronary Artery Calcium Burden in Patients on Hemodialysis
Chronotropic Incompetence Is Associated with Cardiovascular Functional Impairment and Reduced Physical Function in Patients on Hemodialysis
Chronotropic Incompetence Is Associated with Functional Capacity Decline, Poor Quality of Life, and Mortality in Patients with CKD and Heart Failure with Reduced Ejection Fraction
Patient-Reported Outcomes from a Randomized Clinical Trial of SGLT2 Inhibitors in Heart Failure-Associated AKI
GLP-1 Receptor Agonist Use and Patient-Reported Physical Function in CKD
Cardiovascular-Kidney-Metabolic Syndrome and Joint Cognitive-Gait Trajectories Among Older Adults: Health ABC Findings
Effect of Sleep Quality on Arterial Stiffness and Endothelial Function in Patients with Type 1 Diabetes and Kidney Disease: A Pilot Cross-Sectional Analysis
Sleep-Related Symptom Burden and Cardiac Rhythm Abnormalities in Patients with CKD and Obstructive Sleep Apnea
Prevalence and Risks of Alzheimer Disease and Related Dementias by Level of Kidney Function in Patients with Diabetes
Assessment of Multidimensional Frailty and Its Mediating Effect on Adverse Prognosis in Older Adults with CKD
Body Adiposity and Albuminuria in Patients with Type 2 Diabetes Without Obesity: Is There an Association?
Real-World Waist Circumference and Kidney Outcomes: Observational Analysis of US Veterans Affairs Data
Stage-Dependent Associations Between Bariatric Surgery and CKD Outcomes
Temporal Trends and Disparities in Mortality from CKD with Heart Failure and Cerebrovascular Diseases in the United States, 1999-2024
Intersecting Risks: The Interaction of Social Risk and APOL1 Genetic Variants on Cardiometabolic Health in African Americans with CKD
Stage-Dependent Risk of Incident Depression Across Cardiovascular-Kidney-Metabolic Stages: A Nationwide Cohort Study
Associations of Sociodemographic Factors with Statin Use in US Adults with CKD: A Cross-Sectional Analysis of NHANES, 2013-2020
Adverse Social Determinants of Health (SDOH) Are Associated with Higher Odds of Uncontrolled Blood Pressure (BP
Lipid Abnormalities in Patients on Maintenance Hemodialysis (MHD): A Multicenter Study
Critical Care Use Among Patients with ESKD
An Integrated Nephrology-Obesity Medicine Clinic to Improve Weight Management Access for Kidney Transplant Candidates
Effect of Bariatric Surgery on Kidney Function in Morbid Obesity: Reduction of Glomerular Hyperfiltration and Albuminuria in a 10-Year Retrospective Cohort
OBERCE Project: The Burden of Obesity in CKD, a Spanish Multicenter Study